OSA affects more than previously thought

Wednesday, May 23, 2018

SAN DIEGO – Obstructive sleep apnea is more prevalent than previously estimated, with more than 936 million worldwide affected—according to a new data analysis from ResMed. Presented this week at the ATS 2018 International Conference, the study, “Global Prevalence of Obstructive Sleep Apnea (OSA)” was conducted by a group of international researchers seeking to provide a clear scope of the impact of the chronic sleep-disordered breathing condition. The previous estimate of OSA prevalence of 100 million cam from a 2007 World Health Organization study. “This study should encourage physicians to talk with their patients about how sleep affects our overall health,” said ResMed Chief Medical Officer Carlos M. Nunez, M.D. “It should also cause more people to ask themselves, ‘Do I or my bed partner have this?’ Those who have sleep apnea don’t often realize they have it and, therefore, don’t realize they can do something to mitigate the resulting chronic fatigue or its more harmful long-term health risks.”